Pediatrix Medical Group Inc

For the period ended Dec 31, 2024. Filed Feb 20, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 20, 2025

MD$31.49+0.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		Pediatrix Medical Group, Inc.
Date:	February 20, 2025	By:	/s/ Mark S. Ordan
			Mark S. Ordan
			Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.

Guy P. Sansone
Signature	Title	Date
/s/ Mark S. Ordan	Chief Executive Officer and Director	February 20, 2025
Mark S. Ordan	(Principal Executive Officer)
/s/ Kasandra H. Rossi	Chief Financial Officer	February 20, 2025
Kasandra H. Rossi	(Principal Financial Officer and Principal Accounting Officer)
/s/ Guy P. Sansone	Lead Independent Director	February 20, 2025
/s/ Laura A. Linynsky	Director	February 20, 2025
Laura A. Linynsky
/s/ Thomas A. McEachin	Director	February 20, 2025
Thomas A. McEachin
/s/ Michael A. Rucker	Director	February 20, 2025
Michael A. Rucker
/s/ John M. Starcher, Jr.	Director	February 20, 2025
John M. Starcher, Jr.
/s/ Shirley A. Weis	Director	February 20, 2025
Shirley A. Weis
/s/ Sylvia J. Young	Director	February 20, 2025
Sylvia J. Young

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.